A detailed history of Rakuten Investment Management, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Rakuten Investment Management, Inc. holds 14,767 shares of INCY stock, worth $926,776. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,767
Holding current value
$926,776
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$60.0 - $75.26 $886,020 - $1.11 Million
14,767 New
14,767 $894,000
Q3 2024

May 15, 2025

BUY
$57.33 - $68.61 $81,924 - $98,043
1,429 Added 18.6%
9,113 $602,000
Q2 2024

May 15, 2025

BUY
$51.18 - $63.75 $135,319 - $168,555
2,644 Added 52.46%
7,684 $465,000
Q1 2024

May 15, 2025

BUY
$56.55 - $66.59 $258,772 - $304,715
4,576 Added 986.21%
5,040 $287,000
Q4 2023

May 15, 2025

SELL
$52.16 - $64.19 $746,044 - $918,109
-14,303 Reduced 96.86%
464 $29,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $14B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Rakuten Investment Management, Inc. Portfolio

Follow Rakuten Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rakuten Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rakuten Investment Management, Inc. with notifications on news.